close

Leadership Team

Deep knowledge in advancing drug development.

Our team is comprised of world-class scientific advisors, clinicians and innovation leaders. They have the strategic ability to put key pieces in place for driving clinical development forward.

Executive Team

Jerome D. Jabbour
Full Bio

Jerome D. Jabbour

Chief Executive Officer
Keith A. Kucinski, CPA, MBA
Full Bio

Keith A. Kucinski, CPA, MBA

Chief Financial Officer

Board of Directors

Eric J. Ende, M.D., M.B.A
Full Bio

Eric J. Ende, M.D., M.B.A

Chairman of the Board
Jerome D. Jabbour
Full Bio

Jerome D. Jabbour

Chief Executive Officer
Herbert Conrad
Full Bio

Herbert Conrad

Director
James S. Scibetta
Full Bio

James S. Scibetta

Director
Matthew A. Wikler, M.D., M.B.A., F.I.D.S.A.
Full Bio

Matthew A. Wikler, M.D., M.B.A., F.I.D.S.A.

Director
Natasha Giordano
Full Bio

Natasha Giordano

Director

Board Committees

Independent Directors Audit Compensation Nominating and Corporate Governance

Eric J. Ende, M.D., M.B.A

Herbert Conrad

James S. Scibetta

Matthew A. Wikler, M.D., M.B.A., F.I.D.S.A.

Natasha Giordano
Chair
Member

Scientific Advisory Board

Infectious Disease Experts - MAT2203

Prof. Oliver Cornely, M.D., FACP, FIDSA

Professor of Internal Medicine and Attending Physician, Uniklinik Köln

Dimitrios P. Kontoyiannis, M.D., M.S., Sc.D., PhD (Hon),FACP, FIDSA, FECMM

Professor in the Department of Infectious Diseases Infection Control and Employee Health, The University of Texas

Peter G. Pappas, M.D., FACP

Professor of Medicine, University of Alabama

David S. Perlin, Ph.D.

Executive Director, New Jersey Medical School (NJMS), Rutgers Biomedical and Health Sciences